RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today the continuation and expansion of a multi-study agreement with Mitsubishi Tanabe Pharma, a global and research-driven pharmaceutical company. The expanded partnership will give researchers at Mitsubishi Tanabe preferred access to Metabolon’s global biochemical profiling services.
